Stock Track | Rocket Lab USA Soars 9.48% as Musk-Trump Feud Fuels Investor Interest in SpaceX Rivals

Stock Track
08 Jul

Rocket Lab USA, Inc. (RKLB) shares are soaring 9.48% in intraday trading, as investors speculate on potential benefits from the escalating feud between Tesla CEO Elon Musk and former President Donald Trump. The space launch service provider is attracting attention as it positions itself as an alternative to Musk's SpaceX, amid growing political controversy.

The surge in Rocket Lab's stock price comes after Musk announced plans to form a new political party, dubbed the "America Party," to challenge both Republicans and Democrats. This move has drawn criticism from Trump and sparked concerns about potential government contract losses for Musk's companies, including SpaceX. Investors appear to be betting that Rocket Lab, often described as a "mini-SpaceX" with both launch and satellite building capabilities, could benefit from any fallout in the space industry.

While Rocket Lab's market position is still far from that of SpaceX, which handles more than half of all global launches, the company is gaining traction among investors. Analysts expect Rocket Lab to generate about $575 million in revenue by 2025. However, market observers caution that political spats alone are not a solid basis for investment decisions, as relationships and circumstances can change rapidly in the volatile world of politics and technology. The stock's performance in the coming days may provide further insight into the market's perception of Rocket Lab's potential amid the ongoing Musk-Trump feud.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10